Already competing to bring the first vaccine against respiratory syncytial virus (RSV ... to invalidate three GSK patients covering its RSVPreF3 shot, according to a report on the Law360.com ...

AIM Vaccine Co., Ltd., a leading PRC vaccine company, announced today that its independently developed mRNA RSV (respiratory syncytial virus) vaccine has recently been submitted for clinical trials to ...

Revenue for Arexvy and Abrysvo fell sharply year over year in the fourth quarter due to narrower U.S. guidelines for their ...

Even as GSK’s RSV vaccine launch hits a serious slowdown, the British pharma has dialed up its long-term sales guidance once ...

On the flip side, vaccines Prevnar and Abrysvo underperformed expectations. Pfizer expects $1B hit from IRA's Part D redesign and no major M&A in 2025 RSV vaccine Abrysvo specifically floundered ...

What are the symptoms of RSV and who is eligible for a vaccine? - RSV might at first seem like a cold but it can quickly ...

Vaccines are available for the flu, COVID and RSV, and Russo and Omenka say vaccinations could be crucial. "It is important for people to realize that these vaccines are critical for preventing ...

Also, in 2023 RSV vaccines for older adults and pregnant people were finally approved, and that may have protected more individuals. “There’s still a lot of room to [vaccinate] the older ...

This is the season for a rise in RSV cases. We talk to a local doctor on how to treat and stop the spread. Stay up-to-date: The latest headlines and weather from WPBF 25Click here to learn more.

GSK has become the first pharma company to get regulatory approval for a vaccine against respiratory syncytial virus (RSV), setting up what looks set to be a highly lucrative – and likely ...